Westpac Banking Corp held its position in Align Technology, Inc. (NASDAQ:ALGN) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,887 shares of the medical equipment provider’s stock at the close of the second quarter. Westpac Banking Corp’s holdings in Align Technology were worth $884,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. CENTRAL TRUST Co raised its holdings in shares of Align Technology by 128.5% during the 2nd quarter. CENTRAL TRUST Co now owns 697 shares of the medical equipment provider’s stock worth $105,000 after buying an additional 392 shares in the last quarter. Bronfman E.L. Rothschild L.P. raised its holdings in shares of Align Technology by 13.0% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 912 shares of the medical equipment provider’s stock worth $137,000 after buying an additional 105 shares in the last quarter. Trust Co. of Vermont raised its holdings in shares of Align Technology by 15.4% during the 2nd quarter. Trust Co. of Vermont now owns 1,010 shares of the medical equipment provider’s stock worth $152,000 after buying an additional 135 shares in the last quarter. Van ECK Associates Corp raised its holdings in shares of Align Technology by 6.9% during the 1st quarter. Van ECK Associates Corp now owns 1,057 shares of the medical equipment provider’s stock worth $121,000 after buying an additional 68 shares in the last quarter. Finally, Global X Management Co. LLC raised its holdings in shares of Align Technology by 540.3% during the 2nd quarter. Global X Management Co. LLC now owns 1,191 shares of the medical equipment provider’s stock worth $179,000 after buying an additional 1,005 shares in the last quarter. 81.72% of the stock is owned by institutional investors.

Shares of Align Technology, Inc. (NASDAQ:ALGN) opened at 181.44 on Monday. The company has a market cap of $14.54 billion, a price-to-earnings ratio of 62.14 and a beta of 1.55. Align Technology, Inc. has a 12 month low of $83.27 and a 12 month high of $181.99. The company’s 50-day moving average price is $171.56 and its 200-day moving average price is $140.51.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $0.85 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.12. Align Technology had a return on equity of 23.87% and a net margin of 19.18%. The business had revenue of $356.50 million for the quarter, compared to the consensus estimate of $343.43 million. During the same quarter last year, the business posted $0.62 earnings per share. The company’s revenue for the quarter was up 32.3% on a year-over-year basis. Analysts anticipate that Align Technology, Inc. will post $3.40 EPS for the current year.

A number of equities analysts have recently commented on the company. Leerink Swann reissued an “outperform” rating and set a $199.00 price target (up previously from $194.00) on shares of Align Technology in a report on Friday, July 28th. Stifel Nicolaus reissued a “buy” rating and set a $205.00 price target (up previously from $200.00) on shares of Align Technology in a report on Monday, August 7th. Zacks Investment Research cut Align Technology from a “strong-buy” rating to a “hold” rating in a report on Monday, August 21st. Bank of America Corporation raised Align Technology from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $175.00 to $193.00 in a report on Friday, July 28th. Finally, Piper Jaffray Companies restated a “buy” rating and set a $176.00 price objective on shares of Align Technology in a research report on Friday, July 28th. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $174.40.

TRADEMARK VIOLATION WARNING: “Westpac Banking Corp Has $884,000 Stake in Align Technology, Inc. (ALGN)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/09/11/westpac-banking-corp-has-884000-stake-in-align-technology-inc-algn.html.

About Align Technology

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Stock Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related stocks with our FREE daily email newsletter.